Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Pat and GP, I disagree. If the FDA approves the drug for combination therapy the stock will rise substantially. Even the FDA granting an accelerated approval process will cause some interest in the stock.

The question is whether or not PN and his cohorts will ever deliver the drug to market.

Check out the 10 year charts on ARWR and ABUS (was TKMR) and you will see substantial gains way before FDA drug approval which has yet to occur.